Detalhe da pesquisa
1.
Blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.
Blood
; 139(12): 1908-1919, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914826
2.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Am J Hematol
; 98(5): 712-719, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36734029
3.
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
Clin Immunol
; 225: 108679, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485895
4.
Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.
Cytotherapy
; 23(9): 793-798, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215503
5.
Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation.
J Immunol
; 201(5): 1389-1399, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021768
6.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826465
7.
Targeting Immune Checkpoints in Hematologic Malignancies.
Pharmacol Rev
; 68(4): 1014-1025, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664133
8.
Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.
J Biol Chem
; 292(24): 10295-10305, 2017 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468826
9.
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
Clin Immunol
; 192: 6-13, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574039
10.
Results of a Phase Ib Trial of Combination Immunotherapy with a CD8+ T Cell Eliciting Vaccine and Trastuzumab in Breast Cancer Patients.
Ann Surg Oncol
; 24(8): 2161-2167, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28315060
11.
Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.
Biol Blood Marrow Transplant
; 22(10): 1792-1800, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377901
12.
Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
Cancer
; 122(21): 3316-3326, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404668
13.
Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells.
Cancer Immunol Immunother
; 65(6): 741-51, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27129972
14.
PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.
Cytotherapy
; 18(8): 995-1001, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27378343
15.
A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.
Cytotherapy
; 18(8): 985-994, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27265873
16.
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 21(11): 1948-54, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26183077
17.
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
Biol Blood Marrow Transplant
; 20(8): 1139-44, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24727332
18.
Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
J Immunol
; 189(11): 5476-84, 2012 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23105141
19.
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.
Cancer Res Commun
; 4(2): 496-504, 2024 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38335301
20.
Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo.
Res Sq
; 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464203